Hyunsil Han

2.2k total citations · 1 hit paper
14 papers, 1.5k citations indexed

About

Hyunsil Han is a scholar working on Immunology, Oncology and Cancer Research. According to data from OpenAlex, Hyunsil Han has authored 14 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Immunology, 6 papers in Oncology and 4 papers in Cancer Research. Recurrent topics in Hyunsil Han's work include Neutrophil, Myeloperoxidase and Oxidative Mechanisms (5 papers), CAR-T cell therapy research (4 papers) and Immune Response and Inflammation (3 papers). Hyunsil Han is often cited by papers focused on Neutrophil, Myeloperoxidase and Oxidative Mechanisms (5 papers), CAR-T cell therapy research (4 papers) and Immune Response and Inflammation (3 papers). Hyunsil Han collaborates with scholars based in United States, Australia and Brazil. Hyunsil Han's co-authors include Yanming Wang, Sarah Correll, Scott A. Coonrod, Sergei A. Grigoryev, C. David Allis, Lauriebeth Leonelli, Sonja C. Stadler, Danchen Wang, Pingxin Li and Ryo Hayama and has published in prestigious journals such as Journal of Clinical Investigation, The Journal of Experimental Medicine and Journal of Clinical Oncology.

In The Last Decade

Hyunsil Han

14 papers receiving 1.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Histone hypercitrullination mediates chromatin decondensation and neutrophil extracellular trap formation

2009 1.2k citations Yanming Wang, Ming Li et al. The Journal of Cell Biology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Hyunsil Han United States	7	1.1k	508	272	187	166	14	1.5k
Sarah Correll United States	6	1.1k 0.9×	782 1.5×	189 0.7×	178 1.0×	167 1.0×	6	1.6k
Tan Jinquan China	19	778 0.7×	356 0.7×	147 0.5×	93 0.5×	60 0.4×	39	1.4k
Corinne Hiéblot France	18	341 0.3×	496 1.0×	176 0.6×	323 1.7×	87 0.5×	25	1.1k
Paul Chien United States	19	675 0.6×	565 1.1×	228 0.8×	80 0.4×	109 0.7×	40	1.5k
Erdyni N. Tsitsikov United States	21	1.3k 1.1×	545 1.1×	229 0.8×	55 0.3×	116 0.7×	39	1.9k
Sofia Z. Raptis United States	8	504 0.4×	314 0.6×	200 0.7×	103 0.6×	91 0.5×	10	1.0k
Márton Keszei United States	18	603 0.5×	260 0.5×	77 0.3×	69 0.4×	90 0.5×	36	1.1k
Fumiya Hirayama Japan	24	794 0.7×	341 0.7×	109 0.4×	94 0.5×	267 1.6×	103	1.9k
Olivier Spertini Switzerland	15	675 0.6×	378 0.7×	541 2.0×	77 0.4×	55 0.3×	51	1.4k
Hua-Chen Chang United States	17	1.2k 1.1×	311 0.6×	108 0.4×	41 0.2×	103 0.6×	18	1.6k

Countries citing papers authored by Hyunsil Han

Since Specialization

Citations

This map shows the geographic impact of Hyunsil Han's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hyunsil Han with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hyunsil Han more than expected).

Fields of papers citing papers by Hyunsil Han

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hyunsil Han. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hyunsil Han. The network helps show where Hyunsil Han may publish in the future.

Co-authorship network of co-authors of Hyunsil Han

This figure shows the co-authorship network connecting the top 25 collaborators of Hyunsil Han. A scholar is included among the top collaborators of Hyunsil Han based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hyunsil Han. Hyunsil Han is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

1.

Segal, Neil H., Eugenia Girda, Davendra Sohal, et al.. (2024). A phase 1/2 study of REGN7075 in combination with cemiplimab (cemi) in patients (pts) with advanced solid tumors: Efficacy and safety results.. Journal of Clinical Oncology. 42(16_suppl). 2503–2503. 5 indexed citations

2.

Segal, Neil H., Eugenia Girda, Lawrence Fong, et al.. (2023). A phase 1/2 study of REGN7075 (EGFRxCD28 costimulatory bispecific antibody) in combination with cemiplimab (anti–PD-1) in patients with advanced solid tumors: Trial-in-progress update.. Journal of Clinical Oncology. 41(4_suppl). TPS277–TPS277. 5 indexed citations

3.

Johnson, Melissa M., Nehal J. Lakhani, Eugenia Girda, et al.. (2022). 735 A phase 1/2 study of REGN7075 (EGFRxCD28 costimulatory bispecific antibody) in combination with cemiplimab (anti–PD-1) in patients with advanced solid tumors: initial dose-escalation results. Regular and Young Investigator Award Abstracts. A767–A768. 2 indexed citations

4.

Rischin, Danny, Daniel Brungs, Fiona Day, et al.. (2022). C-POST protocol update: A phase 3, randomized, double-blind study of adjuvant cemiplimab versus placebo post-surgery and radiation therapy (RT) in patients (pts) with high-risk cutaneous squamous cell carcinoma (CSCC).. Journal of Clinical Oncology. 40(16_suppl). TPS9592–TPS9592. 2 indexed citations

5.

Lakhani, Nehal J., Melissa L. Johnson, Roman Groisberg, et al.. (2021). 535 A phase I/II study of REGN7075 (EGFRxCD28 costimulatory bispecific antibody) in combination with cemiplimab (anti–PD-1) in patients with advanced solid tumors. SHILAP Revista de lepidopterología. A565–A565. 4 indexed citations

6.

Rischin, Danny, Matthew G. Fury, Israel Lowy, et al.. (2020). A phase III, randomized, double-blind study of adjuvant cemiplimab versus placebo post-surgery and radiation therapy (RT) in patients (pts) with high-risk cutaneous squamous cell carcinoma (CSCC).. Journal of Clinical Oncology. 38(15_suppl). TPS10084–TPS10084. 5 indexed citations

7.

Wang, Yanming, Ming Li, Sonja C. Stadler, et al.. (2009). Histone hypercitrullination mediates chromatin decondensation and neutrophil extracellular trap formation. The Journal of Experimental Medicine. 206(2). i1–i1. 39 indexed citations

8.

Wang, Yanming, Ming Li, Sonja C. Stadler, et al.. (2009). Histone hypercitrullination mediates chromatin decondensation and neutrophil extracellular trap formation. The Journal of Cell Biology. 184(2). 205–213. 1181 indexed citations breakdown →

9.

Han, Hyunsil, A. Stessin, Julia Roberts, et al.. (2005). Calcium-sensing soluble adenylyl cyclase mediates TNF signal transduction in human neutrophils. The Journal of Experimental Medicine. 202(3). 353–361. 54 indexed citations

10.

Han, Hyunsil, et al.. (2005). Chemical inhibitors of TNF signal transduction in human neutrophils point to distinct steps in cell activation. Journal of Leukocyte Biology. 79(1). 147–154. 8 indexed citations

11.

Han, Hyunsil, Michele Fuortes, & Carl Nathan. (2002). Critical Role of the Carboxyl Terminus of Proline-rich Tyrosine Kinase (Pyk2) in the Activation of Human Neutrophils by Tumor Necrosis Factor. The Journal of Experimental Medicine. 197(1). 63–75. 46 indexed citations

12.

Fuortes, Michele, Maxine Melchior, Hyunsil Han, Gholson J. Lyon, & Carl Nathan. (1999). Role of the tyrosine kinase pyk2 in the integrin-dependent activation of human neutrophils by TNF. Journal of Clinical Investigation. 104(3). 327–335. 116 indexed citations

13.

Zhou, Jie, et al.. (1998). Inhibition of TCR/CD3-mediated signaling by a mutant of the hematopoietically expressed G16 GTP-binding protein. European Journal of Immunology. 28(5). 1645–1655. 16 indexed citations

14.

Zhou, Jie, et al.. (1998). Inhibition of TCR/CD3-mediated signaling by a mutant of the hematopoietically expressed G16 GTP-binding protein. European Journal of Immunology. 28(5). 1645–1655. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact